Search Medical Condition
Please enter condition
Please choose location from dropdown

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (277) clinical trials

“I Just Can’t Stop Scratching.” If you’ve said this to yourself before, you might qualify for a clinical study for a new investigational oral medication for the itching associated with atopic dermatitis. Atopic dermatitis patients have difficulty with a variety of symptoms including itch and excessive scratching, lesions, scaring, infection, ...

Phase N/A

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  

Phase N/A

Do you or a loved one have eczema (also called "atopic dermatitis")? If so, you might be interested in a clinical study now enrolling. Wake Research is testing a study drug for eczema and we need people to take part.  

Phase N/A

Chronic itch associated with Prurigo Nodularis

Phase

The purpose of the trial is to test if the trial drug, tralokinumab, is better than placebo or ‘dummy treatment’ at treating moderate to severe atopic dermatitis. This will be judged by a range of assessments that rate the severity and extent of atopic dermatitis, itch and several other symptoms, ...

Phase

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...

Phase

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Phase N/A

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Phase

This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less than 6 years of age with severe atopic dermatitis (AD).

Phase

The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to <12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 ...

Phase